BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26920249)

  • 21. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
    Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
    Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of lncRNA TUBA4B is Associated with Poor Prognosis for Epithelial Ovarian Cancer.
    Zhu FF; Zheng FY; Wang HO; Zheng JJ; Zhang Q
    Pathol Oncol Res; 2018 Apr; 24(2):419-425. PubMed ID: 28578489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Cathepsin K potentiates metastasis of epithelial ovarian cancer.
    Fan X; Wang C; Song X; Liu H; Li X; Zhang Y
    Histol Histopathol; 2018 Jul; 33(7):673-680. PubMed ID: 29303207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
    Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
    J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.
    Hua M; Yan S; Deng Y; Xi Q; Liu R; Yang S; Liu J; Tang C; Wang Y; Zhong J
    Int J Mol Med; 2015 Apr; 35(4):941-9. PubMed ID: 25652936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.
    Ling S; Ruiqin M; Guohong Z; Ying W
    Eur J Gynaecol Oncol; 2015; 36(4):463-8. PubMed ID: 26390704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
    Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
    Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
    Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
    Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.
    Xia D; Yang X; Liu W; Shen F; Pan J; Lin Y; Du N; Sun Y; Xi X
    Biochem Biophys Res Commun; 2017 Apr; 486(1):191-197. PubMed ID: 28286267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
    Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
    Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer.
    Cai X; Wang J; Xin X
    World J Surg Oncol; 2012 Jun; 10():112. PubMed ID: 22713669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
    Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.